Softwr

Healthcare · head to head

Rad AI vs Rx30

Rad AI logo

Rad AI

Healthcare

Generative reporting and follow-up tracking for radiology, positioned outside the diagnostic device boundary

From
On request
Rated
-
Full reviewWebsite
Rx30 logo

Rx30

Healthcare

Long-established pharmacy management system for independents and small chains

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Rad AI the products are not FDA cleared devices and are not intended to be, so any claim that Rad AI improves diagnostic accuracy is unsupported; what has been measured is reporting speed and follow-up completion, not detection.; Rx30 shares ownership with PioneerRx, so the two are not the independent alternatives a shortlist implies, and roadmap priorities are set centrally
  • They diverge on capability: Rad AI covers Impressions, Rx30 covers Prescription processing.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Rad AI and Rx30 actually diverge.

Attributes where Rad AI and Rx30 differ
AttributeRad AIRx30
PlatformsWindows, Web, CloudWindows, Web

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Rad AI

  • Impressions
  • Reporting
  • Continuity
  • Style learning
  • Omni Reconcile
  • PACS and dictation embedding
  • Patient outreach workflows
  • Audit reporting

Only in Rx30

  • Prescription processing
  • Claims adjudication
  • Inventory and purchasing
  • Point of sale
  • Delivery management
  • Clinical documentation

What people use each for

The jobs each tool is most often brought in to do.

Rad AI

  • A private radiology practice whose read volume has grown faster than it can recruit and that wants dictation time per study reduced without changing PACSnot Rx30
  • A health system losing revenue and exposing itself to liability because recommended follow-up imaging on incidental findings is never bookednot Rx30
  • A radiology department standardising impression quality across a mixed group of employed and locum radiologistsnot Rx30
  • A group deploying an AI tool that must not trigger a device validation programme, because governance capacity is already consumed by a triage algorithm rolloutnot Rx30

Rx30

  • Independent pharmacies and small chains wanting a mature, widely-supported systemnot Rad AI
  • Operations relying on a broad set of wholesaler and PBM interfacesnot Rad AI
  • Pharmacies with significant front-end retail alongside dispensingnot Rad AI
  • Multi-store independents needing consistency across locationsnot Rad AI

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Rad AI

  • The products are not FDA cleared devices and are not intended to be, so any claim that Rad AI improves diagnostic accuracy is unsupported; what has been measured is reporting speed and follow-up completion, not detection.
  • Generated impressions require radiologist review and signature, so the time saving evaporates in any group whose radiologists rewrite the draft rather than edit it, and adoption varies sharply by individual.
  • It is bound to your dictation platform, so a group planning to move off PowerScribe should sequence that decision first or expect to redo the Rad AI integration.
  • Continuity depends on the quality of recommendation language in historical reports, and departments with inconsistent phrasing get poor recall until reporting practice is standardised.
  • Pricing is not published and is structured per radiologist or per study depending on the product mix, which makes it hard to compare against image-analysis AI vendors that price per scan.

Rx30

  • Shares ownership with PioneerRx, so the two are not the independent alternatives a shortlist implies, and roadmap priorities are set centrally
  • The interface shows its age against newer entrants, and this is the most common objection in demonstrations
  • Pricing is not published, and total cost including hardware and interfaces needs to be requested explicitly
  • Windows-centric, with a cloud story less developed than newer competitors
  • US-only, tied to US insurance and regulatory requirements

Pricing, plan by plan

Rad AI

On request
  • Rad AI platform$undefined/year
    • Priced per radiologist or per study volume depending on product and contract
    • Impressions, Reporting and Continuity licensed separately
    • Annual subscription with implementation and integration scoped per site

Rx30

On request
  • Rx30$undefined/month
    • Prescription processing
    • Claims adjudication
    • Inventory

Which should you pick?

Choose Rad AI if

  • You need impressions.
  • You work on Windows, Web, Cloud.
  • You also want reporting.
Rad AI review

Choose Rx30 if

  • You need prescription processing.
  • You work on Windows, Web.
  • You also want claims adjudication.
Rx30 review

Questions people ask

Is Rad AI or Rx30 better?
Neither clearly leads. Rad AI starts at On request and Rx30 at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Rad AI or Rx30?
Rad AI starts at On request and Rx30 at On request.
Does Rad AI or Rx30 run on more platforms?
Rad AI runs on Windows, Web, Cloud. Rx30 runs on Windows, Web.
What is Rad AI best used for?
Rad AI is most often used for a private radiology practice whose read volume has grown faster than it can recruit and that wants dictation time per study reduced without changing pacs, a health system losing revenue and exposing itself to liability because recommended follow-up imaging on incidental findings is never booked, a radiology department standardising impression quality across a mixed group of employed and locum radiologists, a group deploying an ai tool that must not trigger a device validation programme, because governance capacity is already consumed by a triage algorithm rollout. Of those, a private radiology practice whose read volume has grown faster than it can recruit and that wants dictation time per study reduced without changing pacs and a health system losing revenue and exposing itself to liability because recommended follow-up imaging on incidental findings is never booked are not what Rx30 is typically brought in for.
What can Rad AI do that Rx30 cannot?
Rad AI covers Impressions, Reporting, Continuity, Style learning. Rx30 covers Prescription processing, Claims adjudication, Inventory and purchasing, Point of sale.

Answered from the vendors’ own pages

Rad AI: Is Rad AI FDA cleared?

No, and by design. The products draft text and manage follow-up workflow rather than interpreting images, so they fall outside the device pathway. Treat any diagnostic accuracy claim with scepticism.

Rx30: Is Rx30 the same company as PioneerRx?

Both are owned by RedSail Technologies. They are sold as separate products to overlapping markets, but roadmap decisions sit with one company, which is worth knowing before treating them as independent options.

Rad AI: Does the radiologist still sign the report?

Yes. Output is a draft that the radiologist reviews and signs; nothing is released autonomously.

Rx30: What does it cost?

Not published. Request the total including hardware, interfaces and training rather than the monthly software fee.

Rad AI: Which product actually pays for itself?

Continuity has the clearest financial case, because recommended follow-up imaging that gets completed is billable work that currently does not happen.

Rx30: Why do pharmacies stay on it?

Installed base maturity. The interfaces to wholesalers, PBMs and hardware are long established, and those are the things that quietly stop a pharmacy working when they break.

Rad AI: Will it work with our dictation system?

It is deepest with Nuance PowerScribe. Confirm your specific dictation and PACS combination before contracting, because integration depth is the main deployment variable.

Rx30: How does it compare to PioneerRx?

PioneerRx is more aggressively developed around clinical services. Rx30 has the larger legacy base and broader front-end retail heritage. Same owner, different emphasis.

Rx30: Is it suitable for a small chain?

Yes, and that is one of its stronger cases. Multi-store consistency is better handled here than by the systems aimed purely at single independents.

Share

Related pages

More on Rad AI

More on Rx30

Keep looking

Other head to heads